NASDAQ:DRTS
Alpha Tau Medical Ltd. Stock Company Profile
$2.59
+0.120 (+4.86%)
At Close: May 10, 2024
Information
5 Kiryat Hamada Street
Jerusalem 9777605
972 3 577 4115
www.alphatau.com
Industry: Biotechnology
Sector: Healthcare
Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
